Genmab — Juni 2025

[Solsen]

Nej der er sikkert ikke noget i det.

[ProinvestorNEWS]

Europa/aktier: Sundhedsaktier vinder frem mens investorer kigger mod toldforhandlinger https://proinvestor.com/investornyt/1325611/europa-aktier-sundhedsaktier-vinder-frem-mens-investorer-kigger-mod-toldforhandlinger

[Legolas23]

FDA vil fremskynde godkendelsen af lægemidler til sjældne sygdomme https://medwatch.dk/Medicinal___Biotek/article18253942.ece?utm_campaign=MedWatch Middag&utm_content=2025-06-06&utm_medium=email&utm_source=medwatch

[bikube]

Det er da positivt, at han vil sætte tempoet op, men hvis det går ud over sikkerheden i deres arbejde, er det jo ikke entydigt godt. Man kan vel så påregne, at der skal køres fase 4 på nogle godkendte stoffer.

[gentogen]

Fra samme kilde.......https://medwatch.dk/Medicinal___Biotek/article18073152.ece

[Solsen]

Lidt om samarbejdet med Lundbec https://www.researchgate.net/publication/392007308_Rational_selection_of_the_monoclonal_a-synuclein_antibody_amlenetug_Lu_AF82422_for_the_treatment_of_a-synucleinopathies/fulltext/683034fb6b5a287c3043f3cb/Rational-selection-of-the-monoclonal-a-synuclein-antibody-amlenetug-Lu-AF82422-for-the-treatment-of-a-synucleinopathies.pdf?origin=publication_detail&_tp=eyJjb250ZXh0Ijp7ImZpcnN0UGFnZSI6InByb2ZpbGUiLCJwYWdlIjoicHVibGljYXRpb25Eb3dubG9hZCIsInByZXZpb3VzUGFnZSI6InB1Y

[Solsen]

..Lundbeck. Ved ikke om jeg rigtigt tror på stoffet

[ProinvestorNEWS]

Knock-Your-Socks-Off-News – June 2025 https://www.linkedin.com/pulse/knock-your-socks-off-news-june-2025-genmab-p3wze/

[E_L]

Indirect comparison of epcoritamab vs chemoimmunotherapy, mosunetuzumab, or odronextamab in follicular lymphoma https://www.sciencedirect.com/science/article/pii/S2473952925003143

[Raun]

Biontech BNT116 -
https://x.com/EvanKirstel/status/1932149953184375160

[Solsen]

Det bliver spændende at følge @Raun

[E_L]

the Ph3 Acasunlimab trial adding a lot of new recruitment centers https://clinicaltrials.gov/study/NCT06635824?tab=history&a=8&b=9&compareMode=sideBySide#version-content-panel

[w]

AlphaValue/Baader Europe Keeps Genmab at Buy, Boosts Price Target on Pipeline Strength. Hæver fra 2566 til 2661kr

[w]

Human Verification

(finimize.com)

[Solsen]

Plus 100 new sites And boost targets. Are we back on trac ?

[E_L]

In full swing... let's see if they can replicate the speed with which they executed on Epcoritamab... that went very fast (is going very fast i should say), but this they have to do alone...

[E_L]

ASCO 2025 presentations via https://www.genmabmedicalaffairs.com/congress?filv1=17

[Solsen]

Looks like Rina-S also are running fast

[Solsen]

I have been a little cautious on Acasunlimab after Biontech left. But there is a chance that Biontech where wrong.

[E_L]

the fact that they started a Melanoma trial with Acasunlimab is a strong signal i would think